McKesson (MCK) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US58155Q1031

McKesson Corporation, listed on the NYSE as MCK, is a prominent healthcare services provider operating not only in the United States but also on the global stage. Established in 1833 and based out of Irving, Texas, the company is categorized into four distinctive segments.

The U.S. Pharmaceutical sector primarily deals with the distribution of a wide range of pharmaceutical products, including branded, generic, specialty, biosimilar, and over-the-counter medications. Additionally, it offers various services like practice management, technology solutions, and clinical support to specialty practices, particularly in the field of oncology.

The Prescription Technology Solutions (RxTS) division focuses on addressing medication challenges faced by patients by collaborating with various stakeholders in the healthcare industry. Its innovative solutions aim to connect patients, pharmacies, healthcare providers, pharmacy benefit managers, health plans, and biopharma companies.

McKesson's Medical-Surgical Solutions arm provides crucial services such as medical-surgical supply distribution and logistics to various healthcare providers, ranging from physician offices to hospital reference labs. It plays a significant role in ensuring the seamless operation of healthcare facilities.

Lastly, the International segment of McKesson Corporation extends its distribution and service offerings to wholesale, institutional, and retail customers in Europe and Canada, further solidifying the company's global presence.

In conclusion, McKesson Corporation stands as a distinguished entity in the healthcare sector, with a robust portfolio of services aimed at enhancing medical outcomes and patient well-being. For more information, you can visit their website at

AI improved, may contain errors or wrong assumptions

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for McKesson (MCK) - Stock Price & Dividends

MCK Stock Overview

Market Cap in USD 67,157m
Sector Healthcare
Industry Medical Distribution
GiC SubIndustry Health Care Distributors
TER 0.00%
IPO / Inception 1994-11-15

MCK Stock Ratings

Fundamental 5.27
Dividend 7.10
Growth 5y 9.63
Rel. Performance vs Sector 2.40
Analysts 4.11
Fair Price Total Ret. 624.88
Fair Price DCF 603.20

MCK Dividends

Yield 12m 0.34%
Yield on Cost 5y 1.49%
Dividends CAGR 5y 7.71%
Payout Consistency 97.4%

MCK Growth Ratios

Growth 12m 49.51%
Growth Correlation 12m 86%
Growth Correlation 3m 75%
CAGR 5y 35.27%
CAGR / Mean Drawdown 7.14
Sharpe Ratio 12m 2.20
Alpha vs SP500 12m 26.74
Beta vs SP500 5y weekly 0.70
CAPM 7.17%
Average Daily Range 2m 1.74%
Regime Oscillator 88.73
Volatility GJR Garch 1y 24.64%
Price / SMA 50 7.51%
Price / SMA 200 18.36%
Current Volume 475.2k
Average Volume 20d 837k

External Links for MCK Stock

Wall Street JournalBenzingaYahoo Finance
X (Twitter)Stocktwits
Fund Manager Positions
What is the price of MCK stocks?
As of February 29, 2024, the stock is trading at USD 523.68 with a total of 475,188 shares traded.
Over the past week, the price has changed by +3.20%, over one month by +7.65%, over three months by +13.60% and over the past year by +48.22%.
Why is MCK stock down?
Check with which Index or Commodity MCK has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return MCK Return S&P 500
1 Month 7.65% 3.05%
3 Months 13.60% 11.73%
12 Months 48.22% 29.22%
What is the forecast for MCK stock price target?
According to ValueRays Forecast Model, MCK McKesson will be worth about 688.4 in February 2025. The stock is currently trading at 523.68. This means that the stock has a potential upside of +31.45%.
Issuer Forecast Upside
Wallstreet Target Price 543.2 3.7%
Analysts Target Price 486.3 -7.1%
ValueRay Target Price 688.4 31.4%

McKesson Corporation: History, Business Segments, and Market Status

History of McKesson Corporation

McKesson Corporation, today a titan in the healthcare sector, has a rich history that traces back to 1833. Founded by John McKesson and Charles Olcott in New York City as Olcott & McKesson, it started off by selling therapeutic drugs and chemicals wholesale. Throughout the years, McKesson has evolved, undergoing numerous transformations and absorbing several entities to cement its place in the healthcare industry. This expansive timeline has seen McKesson transition from a simple drugstore to a global healthcare services and information technology company, exemplifying its adaptability and forward-thinking approach.

Core and Side Businesses of McKesson

Core Business

At the heart of McKesson's operations is its pharmaceutical distribution and healthcare services. The company stands as one of the largest distributors of pharmaceuticals in the world, supplying drugs, medical supplies, and health information technology (IT) products and services across multiple channels. This core segment focuses on improving supply chain efficiencies, reducing healthcare costs, and delivering better health outcomes.

Side Businesses

Alongside its primary focus, McKesson operates several side businesses, including medical surgical solutions, and various technology-based services aimed at enhancing pharmacy management, automating clinical workflows, and improving inventory management. Furthermore, McKesson is involved in retail pharmacy chains and specialty health services, catering to specific patient needs across oncology, rheumatology, and other fields. These diversified service areas exemplify McKesson’s commitment to addressing the comprehensive needs of the healthcare system.

Current Market Status

As of the latest updates in 2023, McKesson Corporation (NYSE:MCK) continues to be a dominant force in the healthcare supplier and technology market. With its strategic expansions and partnerships, the company has maintained a robust position in the market. McKesson's financial performance reflects its operational success, showcasing sustained revenue growth and a strong market capitalization. The company's ongoing efforts to innovate within the healthcare sector, combined with its commitment to corporate responsibility, position it well for continued success in addressing the dynamic needs of the healthcare industry.